FFCP PHASE1:Hg19::chr11:23621457..23621480,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(7 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{{FFCP | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |EntrezGene=NA | ||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=NA | |HGNC=NA | ||
|TSSclassifier=strong | |||
|UniProt=NA | |UniProt=NA | ||
|association_with_transcript=NA | |association_with_transcript=NA | ||
|cluster_id=chr11:23621457..23621480,+ | |||
|coexpression_cluster_id=C62 | |||
|description=CAGE_peak_at_chr11:23621457..23621480,+ | |description=CAGE_peak_at_chr11:23621457..23621480,+ | ||
|id=chr11:23621457..23621480,+ | |id=chr11:23621457..23621480,+ | ||
|ontology_enrichment_celltype=CL:0000819!2.39e-66!1;CL:0000785!5.04e-34!2;CL:0000955!5.04e-34!2;CL:0000818!5.04e-34!2;CL:0000954!5.04e-34!2;CL:0000816!5.04e-34!2;CL:0000817!3.27e-23!3;CL:0000945!3.75e-12!24;CL:0000826!3.75e-12!24;CL:1000507!8.38e-07!12;CL:1000494!8.38e-07!12 | |ontology_enrichment_celltype=CL:0000819!2.39e-66!1;CL:0000785!5.04e-34!2;CL:0000955!5.04e-34!2;CL:0000818!5.04e-34!2;CL:0000954!5.04e-34!2;CL:0000816!5.04e-34!2;CL:0000817!3.27e-23!3;CL:0000945!3.75e-12!24;CL:0000826!3.75e-12!24;CL:1000507!8.38e-07!12;CL:1000494!8.38e-07!12 | ||
|ontology_enrichment_celltype_v019=CL:0000785;2.55e-98;1!CL:0000819;2.55e-98;1!CL:0000945;1.03e-17;24!CL:0000542;3.95e-11;53!CL:0000236;5.70e-09;13 | |||
|ontology_enrichment_celltype_v019_2=CL:0000819,2.55e-98,1;CL:0000785,4.52e-50,2;CL:0000955,4.52e-50,2;CL:0000818,4.52e-50,2;CL:0000954,4.52e-50,2;CL:0000816,4.52e-50,2;CL:0000817,5.96e-34,3;CL:0000945,1.03e-17,24;CL:0000826,1.03e-17,24;CL:0000838,6.99e-09,52;CL:0000542,9.74e-09,53;CL:0000051,9.74e-09,53;CL:0000236,2.00e-08,14 | |||
|ontology_enrichment_development_v019=CL:0000954;4.52e-50;2!CL:0000051;3.95e-11;53 | |||
|ontology_enrichment_disease=DOID:0060073!2.39e-66!1;DOID:8675!2.39e-66!1;DOID:0060058!2.08e-27!10 | |||
|ontology_enrichment_disease_v019=DOID:0060073;2.55e-98;1!DOID:8675;2.55e-98;1!DOID:0060058;2.00e-40;10!DOID:2531;8.57e-09;51!DOID:0060083;8.57e-09;51 | |||
|ontology_enrichment_disease_v019_2=DOID:0060073,2.55e-98,1;DOID:8675,2.55e-98,1;DOID:0060058,2.00e-40,10;DOID:2531,4.95e-09,51;DOID:0060083,4.95e-09,51 | |||
|ontology_enrichment_uberon=UBERON:0009773!8.38e-07!12;UBERON:0001231!8.38e-07!12;UBERON:0004810!8.38e-07!12 | |ontology_enrichment_uberon=UBERON:0009773!8.38e-07!12;UBERON:0001231!8.38e-07!12;UBERON:0004810!8.38e-07!12 | ||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.17615522379237,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.105551628892876,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.45963831372533,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.17615522379237,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.105551628892876,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.45963831372533,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | ||
|short_description=p@chr11:23621457..23621480,+ | |short_description=p@chr11:23621457..23621480,+ | ||
}} | }} |
Latest revision as of 21:10, 23 July 2015
Short description: | p@chr11:23621457..23621480, + |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr11:23621457..23621480, + |
Coexpression cluster: | C62_Burkitt_tonsil_CD19_submaxillary_spleen_salivary_lymph |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
B-1 B cell | 2.55e-98 | 1 |
mature B cell | 4.52e-50 | 2 |
pre-B-II cell | 4.52e-50 | 2 |
transitional stage B cell | 4.52e-50 | 2 |
small pre-B-II cell | 4.52e-50 | 2 |
immature B cell | 4.52e-50 | 2 |
precursor B cell | 5.96e-34 | 3 |
lymphocyte of B lineage | 1.03e-17 | 24 |
pro-B cell | 1.03e-17 | 24 |
lymphoid lineage restricted progenitor cell | 6.99e-09 | 52 |
lymphocyte | 9.74e-09 | 53 |
common lymphoid progenitor | 9.74e-09 | 53 |
B cell | 2.00e-08 | 14 |
Ontology term | p-value | n |
---|---|---|
lymphatic system cancer | 2.55e-98 | 1 |
lymphosarcoma | 2.55e-98 | 1 |
lymphoma | 2.00e-40 | 10 |
hematologic cancer | 4.95e-09 | 51 |
immune system cancer | 4.95e-09 | 51 |